Pharmacokinetics (PK) and Safety Study of XARTEMIS® XR in Postsurgical Adolescent Subjects With Moderate to Severe Acute Pain
NCT02508935
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
23
Enrollment
INDUSTRY
Sponsor class
Stopped
Business decision
Conditions
Acute Pain
Interventions
DRUG:
XARTEMIS XR
Sponsor
Mallinckrodt